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Abstract: Prevalence of asthma in Australian children is amongst the highest in the world. Although
breastfeeding positively influences infant immunity, early introduction of Milk Other than Breast Milk
(MOTBM) may also play an important role in the development of Asthma. The aim of this study was
to investigate the association between the introduction of MOTBM in the first six months after birth
and the development of reported persistent asthma in 3-year olds. A sample of 1121 children was
extracted from the Environments for Healthy Living longitudinal birth cohort study. Introduction of
MOTBM during the first six months after birth increased almost two-fold the risk of development of
persistent asthma after adjusting for other covariates (Adjusted Relative Risk (ARR): 1.71, 95% CI:
1.03–2.83, p = 0.038). This study indicates that the introduction of MOTBM in the first six months
of life is a risk factor for asthma incidence among 3-year old children. This result is important in
explaining the benefits of breastfeeding as part of public health interventions to encourage mothers
to increase breastfeeding initiation and duration, and avoid the introduction of MOTBM in the first
six months after childbirth.
Keywords: asthma; breastfeeding; milk other than breast milk
1. Introduction
Asthma is a major public health issue predominantly facing developed countries, including
Australia [1]. It is the most common chronic disease among children [2]. The prevalence of asthma in
Australian children is amongst the highest in the world [3]. The worldwide prevalence of childhood
asthma has been increasing considerably in the last few years [4]. Explanations for this increase are not
yet clear, thus limiting the opportunities to develop targeted primary prevention measures [4].
According to hygiene hypothesis, changes of lifestyle in industrialized and western countries,
in combination with limited exposure to microorganisms such as viruses and bacteria during early
childhood, increase the susceptibility to allergic diseases including asthma [5]. Children raised in
developed cities like those in Australia are exposed to indoor and outdoor allergens and irritants
during their early years of life. This may have tipped the balance of the child’s immune system from a
TH1 (no asthmatic) to a TH2 (asthmatic) phenotype response [6].
Clinically, asthma is defined as a chronic inflammatory disorder of the lungs. It is characterized by
recurrent episodes of wheezing, shortness of breath, tightness of chest, and coughing, associated with
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limitation of airflow in the respiratory system [7]. Asthma and other allergic diseases are often linked
to the immune system and inflammation response. This is because the immune system is thought to be
a regulator of asthma and airways inflammations by producing immune factors in response to stimuli
and foreign bodies [8].
Defining asthma through testing lung function is challenging before the age of 5 [9]. Nonetheless,
several studies monitored early signs of asthma during the first 3 years of the infant’s life to test
for the impact of various factors on development of asthma in later life [10–12]. Several studies
documented a number of factors that may increase the likelihood of developing asthma, like maternal
asthma [13], young maternal age [14], low level of mother’s education [15], Aboriginality [16],
child sex [17], maternal smoking during pregnancy [18], early gestational age [19], caesarean
section [20], prematurity [21], low birth weight [22], the existence of eczema [23], and food allergies [24].
Infant feeding is an important early-life exposure that may influence the development of
asthma [7]. The components of breast-milk stimulate the infant’s own immune system, safeguarding
them against the development of allergic disease [7]. Although breastfeeding provides health
benefits against respiratory infections and maturation of the infant’s immunity [25], findings of
many studies assessing the role of breastfeeding in decreasing the risk of asthma development have
been controversial [7,26–28]. Moreover, Milk Other than Breast Milk (MOTBM) is usually introduced
early in infant life for many reasons [29], and the link between the early introduction of MOTBM and
the development of Asthma has yet to be discovered.
Most infant formulas are derived from standard cow’s milk, which contains powerful food
allergens [30]. There is some evidence of association between infant consumption of cow’s milk in the
initial few months of life and the development of asthma [30]. Numerous studies were conducted
on MOTBM feeding and its effect on development of Asthma [30–33]. These studies, however,
were focusing on comparing the effects of various types of MOTBM, such as cow milk, goat milk,
soymilk or hydrolyzed milk, on increasing or decreasing the risk of development of Asthma relative
to each other. Some results showed that certain types of these MOTBM, such as hydrolyzed formula,
reduce the risk of developing asthma [30,31,34]. However, the effect of any type of MOTBM in
increasing the risk of development of Asthma relative to breast milk was not studied.
Hence, the aim of our study is to assess whether the introduction of any type of MOTBM during the
first 6 months after birth increases the risk of later development of asthma among 3-year old children.
2. Materials and Methods
2.1. The Environments for Healthy Living Study
The Environments for Healthy Living study (EFHL) is a prospective, multi-level, multi-year
longitudinal birth cohort study with six recruitment years from 2006 to 2011. The study was registered
with the Australian New Zealand Clinical Trials Registry (ACTRN12610000931077). The study
recruited pregnant women from three geographically-defined, contiguous Health Districts in Australia
(Logan City and Gold Coast in Queensland, and the Tweed area in New South Wales) [35]. Perinatal
data were obtained from maternal medical records following discharge from hospital completed by
the hospital midwives. Data items included maternal conditions, obstetric complications, delivery
information, and child information such as gender, gestational age, and birth weight [36].
The EFHL study was approved by the Griffith University Human Research Ethics Committee
(Research ethics approval No is MED/16/06/HREC, MED/23/11/HREC). Additional ethical approval
for participant recruitment was also obtained from each of the three participating public maternity
hospitals (Logan Hospital HREC/06/QPAH/96, Gold Coast Hospital HREC/06/GCH/52, The Tweed
Hospital NCAHS HREC 358N). A consent form was read and signed by each participant who agreed
to release the hospital perinatal data related to the birth of her child, complete a maternal baseline
questionnaire, and to individual follow-up [36].
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When EFHL infants turned 1, the primary carers, predominantly the mothers, completed a
questionnaire (wave 1) that included questions about demographics, household socioeconomics,
child feeding and diet, child health, and development (including medically diagnosed asthma and
food allergy). When the children reached 3 and 5 years of age, the primary carers were again contacted
and completed similar questionnaires (wave 2 and 3).
2.2. Study Population
Children aged 3 from the EFHL study were included in this study. These children were recruited
between 2006 and 2010 with follow-ups at 1 and 3 years of the study waves 1 and 2 respectively
(Figure 1). Twins were handled as unrelated children (17 children (1.7%)).
Figure 1. Study cohort, wave 1 (solid border) and wave 2 (dash border).
2.3. Study Variables
The outcome variable, reported Medically-diagnosed persistent asthma, was derived from a question
to the carer on whether the child has ever been diagnosed by a medical doctor with wheezing or asthma.
A child was considered to have medically-diagnosed persistent asthma if the carer indicated that the
child was diagnosed with asthma at both the 1 (wave 1) and 3 years of age (wave 2) follow-ups. Since the
outcome variable focused on persistent asthma only, children whose asthma status was not constant at
both waves were not considered to have persistent asthma, and thus, were excluded from the study.
The main exposure variable is the introduction of MOTBM at less than six months after birth,
derived from the question: “How old was your child when he/she first had any other type of milk in a
cup or a bottle? (e.g., formula, cow’s milk, soy milk)”.
Covariates were selected from the literature [13–24]. Those related to the child included: whether
stopped breastfeeding at <6 months of age, gender, delivered by caesarean section, low birth weight
(weight < 2500 g), preterm delivery (gestational age < 37 weeks), frequency of exposure to cigarettes
smoke (derived from the question: “Indicate how regularly the baby is in a room or enclosed place
where other people are smoking”), ever been diagnosed with eczema, and ever diagnosed with food
allergy. Those related to the mother were: age in years, level of education, place of birth, indigenous
status, average number of cigarettes smoked each day on average at >20 weeks of pregnancy and
treatment of asthma during pregnancy.
2.4. Statistical Analyses
Medically-diagnosed persistent asthma was analyzed as a binary outcome variable. Percentages,
means and standard deviations were used to describe the data. Logistic regression analyses were used
to model the risk of medically-diagnosed persistent asthma in relation to introduction of MOTBM
at less than six months after birth and other potential confounding variables. Purposeful selection
method was used to build the models. Initially, univariate logistic regression analyses were performed
to select variables to be included in the multivariable logistic regression analyses. Variables with
p-values < 0.25 were considered to develop an initial reduced model [37]. Using adjusted Wald
tests, variables that tested insignificant (with p-values > 0.05) were then eliminated from this model.
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Insignificant variables were included one at a time, and assessed for significance and for confounding
effects using a 10 percent [38] change in the coefficients. Likelihood ratio tests were used to compare
models. Variance inflation factors were used to assess multicollinearity among variables. Hosmer and
Lemeshow goodness-of-fit tests [39] were used to assess goodness of fit of the final model. With a low
incidence of the outcome, Relative Risks (RR), Adjusted Relative Risks (ARR) and their 95% confidence
intervals were approximated from the corresponding Odds Ratios (OR) obtained from the logistic
regression analyses. STATA 15.0 was used for all analyses [40].
3. Results
Information was obtained on 2907 children whose mothers were enrolled in the study from 2006 to
2010. About 51% of the children were lost to follow-up either at waves 1 or 2, or had incomplete
mothers’ perinatal data. A total of 1342 children had complete information on reported medical
diagnosis of asthma at the 1 year (wave 1) and 3 years (wave 2) follow-ups. Children who had
consistently reported medically-diagnosed persistent asthma at both waves were included in the study,
as well as those who had not (n = 1138). Those whose asthma status was not constant at both waves
were excluded (n = 204). Out of the 1138 children, 17 with missing information on MOTBM were also
excluded. The analytical study cohort became 1121 children.
3.1. Characteristics of the Study Cohort
Among 1121 children, about 7% of children had persistent asthma at the age of 3, and 51% received
MOTBM at less than six months after birth. There were slightly more females (51.7%) than males
(47.8%). About one-third of the children (31.2%) were delivered by caesarean section, and most
were born full term (97.8%) and had normal birth weight (97.9%). Sixty-two percent of the mothers
were aged 26–35 years, and only a quarter completed university (24.8). Mothers were mostly born in
Australia (72.2%), not Aboriginal/TSI (96.5%), and did not smoke cigarettes each day during pregnancy
(89.2%). Key characteristics of the cohort are detailed in Tables 1 and 2.
Table 1. Characteristics of children: overall and those with persistent asthma at end of follow-up.
Total Persistent Asthma
Total
% No. %
Total 100.0 76 6.8 1121
MOTBM introduced at <6 months
No 49.0 26 4.7 549
Yes 51.0 50 8.7 572
Stopped breastfeeding at <6 months
No 39.5 28 6.3 443
Yes 60.5 48 7.1 678
Gender
Male 47.8 56 10.4 536
Female 51.7 20 3.4 580
Delivered by caesarean section 1
No 68.4 49 7.7 767
Yes 31.2 27 6.4 350
Low birth weight (Weight < 2500 g)
No 97.9 75 6.8 1098
Yes 2.1 1 4.3 23
Preterm delivery (Gestational age < 37 weeks)
No 97.7 73 6.7 1095
Yes 2.3 3 11.5 26
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Table 1. Cont.
Total Persistent Asthma
Total
% No. %
Frequency exposed to cigarettes smoke 1
Sometimes 6.3 8 11.3 71
Not at all 93.6 68 6.5 1049
Ever been diagnosed with eczema
No 89.9 61 6.1 1008
Yes 10.1 15 13.3 113
Even been diagnosed with food allergy
No 95.7 71 6.6 1073
Yes 4.3 5 10.4 48
1 0.1–0.4% missing data.
Table 2. Characteristics of mothers: overall and those with children with persistent asthma at end
of follow-up.
Total Persistent Asthma Total
% No. % No.
Age in years
16–25 17.9 22 10.9 201
26–30 30.9 19 5.5 346
31–35 31.1 26 7.4 349
36–45 20.1 9 4.0 225
Highest level of education 1
Did not complete high school 14.4 12 7.5 161
Completed high school 29.6 28 8.4 332
TAFE/trade or apprenticeship 30.8 27 7.8 345
University degree 24.8 8 2.9 278
Place of birth
Elsewhere 27.8 18 5.8 312
Australia 72.2 58 7.2 809
Indigenous status 2
Aboriginal/TSI 1.4 0 0.0 16
Otherwise 96.5 75 6.9 1082
Average number of cigarettes smoked each day during pregnancy 1
0 89.2 62 6.2 1000
≤10 5.4 4 6.6 61
>10 4.7 10 18.9 53
Treatment for asthma during pregnancy (n = 864) 3
No 75.4 66 7.9 839
Yes 2.2 4 16 25
1 0.4–0.6% missing data, 2 2% missing data. 3 Question asked only to QLD state participants.
There were some differences in the characteristics of the study children when compared to the
excluded children who were either lost to follow-up (51%, n = 1484) or had missing information
(10%, n = 302). Mothers in the study sample were older (51.2% were 31+ years old) than those in the
excluded sample (35.7% were 31+ years) (p < 0.001). They were also more educated, with 85.6% of
them completing at least high school compared to 75.1% in the excluded sample (p < 0.001). Cigarettes
smoking during pregnancy was less prevalent in the study sample (4.8%) than in the excluded sample
(10%) (p < 0.001). There were more females (52%) in the study sample than in the excluded sample
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(47.7%) (p = 0.025). More children were delivered by caesarean section (31.3%) in the study sample
than in the excluded sample (27%) (p = 0.013). There was also a lower representation of preterm
children in the study sample (2.3%), versus the excluded sample (3.9%) (p = 0.023). Fewer children in
the study sample (6.3%) were sometimes exposed to cigarettes smoke than in the excluded sample
(9.4%) (p = 0.012). Moreover, less children in the study sample had MOTBM at less than six months
after birth (51%) compared to the excluded sample (61.2%) (p < 0.001). All other characteristics were
not significantly different.
3.2. Association between Developing Persistent Asthma and MOTBM and Other Covariates
Tables 1 and 2 also report the associations between developing persistent asthma and MOTBM
and other covariates. More children who were introduced to MOTBM at less than six months after birth
(8.7%) had persistent asthma compared to those who were not introduced (4.7%). Persistent asthma
was much more prevalent among males (10.4%) compared to females (3.4%). Younger (16–25 years)
(10.9%) and less educated mothers (8.0%) had higher percentages of children with persistent asthma
than older ones (5.9%) and mothers who completed university (2.9%) respectively. Although only 10%
of children were ever diagnosed with eczema, the diagnosis of persistent asthma was almost twice in
this group (13.3%) compared to those who were not diagnosed with eczema (6.1%). A similar pattern
was seen for children who had been diagnosed with a food allergy. The percentage of children with
persistent asthma was much higher among those who were sometimes exposed to cigarettes smoke
(11.3%) than those who were never exposed to smoke (6.5%). Moreover, the level of passive smoking
based on the total number of cigarettes smoked by mothers during their pregnancies per day did not
show a dose-response effect. Persistent asthma was recorded in 18.9% of children who were exposed
to tobacco smoke of more than 10 cigarettes/day, while this percentage was about 6% for both children
of mothers who smoked less than 10 cigarettes/day or did not smoke at all.
Table 3 summarizes the results of univariate and multivariable logistic regression modeling of the
risk of medically-diagnosed persistent asthma in relation to other variables. Univariate analysis did
not reveal any associations with child cesarean section delivery, low birth weight, preterm delivery,
whether child stopped breastfeeding at less than 6 months, or the frequency at which the child was
exposed to cigarette smoke. Although the mother’s level of education was significant in the univariate
analysis, it became insignificant in the final built multivariable model. The final model demonstrated
that introduction of MOTBM in the first 6 months of life increased the risk of children having persistent
asthma by 3 years of age by 71% after adjusting for other covariates (ARR: 1.71, 95% CI: 1.03–2.83,
p-value = 0.038). Children diagnosed with eczema, being male, and whose mothers’ smoked during
pregnancy were associated with an increased risk of persistent asthma in children at the age of 3 after
adjusting for other covariates. Although maternal age was significantly associated with persistent
asthma in children (p < 0.001), the direction of the relationship was not consistent. Women in the
16–25 and 31–35 age groups were at higher risk compared 26–30 and 36–45 age groups.
Table 3. Univariate and multivariable Logistic regression modeling the likelihood of medically-diagnosed
persistent asthma.
Univariate Analysis Multivariable Analysis
RR [95% CI] p-Value 1 ARR [95% CI] p-Value 2
MOTBM introduced at <6 months 0.009
No 1.00 1.00
Yes 1.93 [1.18, 3.14] 1.71 [1.03, 2.83] 0.038
Stopped breastfeeding at <6 months 0.621
No 1.00
Yes 1.13 [0.70, 1.83]
Gender <0.001
Male 1.00 1.00
Female 0.31 [0.18, 0.52] 0.31 [0.18, 0.53] 0.000
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Table 3. Cont.
Univariate Analysis Multivariable Analysis
RR [95% CI] p-Value 1 ARR [95% CI] p-Value 2
Delivered by caesarean section 0.415
No 1.00
Yes 1.22 [0.75, 1.99]
Low birth weight (Weight < 2500 g) 0.642
No 1.00
Yes 0.62 [0.08, 4.66]
Preterm delivery (Gestational age < 37 weeks) 0.336
No 1.00
Yes 1.83 [0.54, 6.22]
Frequency exposed to cigarettes smoke 0.126
Sometimes 1.00
Not at all 0.55 [0.25, 1.19]
Ever been diagnosed with eczema 0.005
No 1.00 1.00
Yes 2.38 [1.30, 4.34] 2.15 [1.15, 4.04] 0.017
Even been diagnosed with food allergy 0.310
No 1.00
Yes 1.64 [0.63, 4.27]
Age in years 0.028
16–25 1.00 1.00
26–30 0.47 [0.25, 0.90] 0.47 [0.24, 0.92] 0.028
31–35 0.65 [0.36, 1.19] 0.67 [0.36, 1.25] 0.206
36–45 0.34 [0.15, 0.75] 0.33 [0.15, 0.75] 0.009
Highest level of education 0.015
Did not complete high school 1.00
Completed high school 1.14 [0.57, 2.31]
TAFE/trade or apprenticeship 1.05 [0.52, 2.14]
University degree 0.37 [0.15, 0.92]
Place of birth 0.404
Elsewhere 1.00
Australia 1.26 [0.73, 2.18]
Average number of cigarettes smoked each day during pregnancy 0.001 3 <0.001 3
0 1.00 1.00
≤10 1.06 [0.37, 3.02] 0.89 [0.30, 2.61] 0.831
>10 3.52 [1.69, 7.33] 4.23 [1.91, 9.37] <0.001
Treatment for asthma during pregnancy (n = 864) 4 0.004 - -
No 1.00 - -
Yes 2.23 [0.74, 6.69] - -
1 Likelihood ratio p-value; 2 Wald test p-value; 3 Test for trend; 4 Question asked only to QLD state participants
(not included in multivariable analysis); Multivariable analysis: RR are approximated by OR. Hosmer and Lemeshow
goodness and fit test p-value = 0.929, 93% correct classification.
4. Discussion
All screened studies compared the effects of different types of MOTBM on increasing or decreasing
the risk of asthma; however, all of these studies compared the effects of different types of MOTBM
relative to each other. To our knowledge, this research is the first to assess whether MOTBM, regardless
of its source, increases the risk of development of asthma.
There are three major types of infant formulas: standard cow’s milk-based formulas, soy-based
formulas, and hypoallergenic formulas (hydrolysed cow’s milk formulas) [41]. Previous studies
assessing standard cow-based formulas found that these formulas were not protective against asthma
during infancy or childhood [30,42]. Similarly, soy-based formula did not reduce the risk of asthma
when compared with standard cows-based milk formula in infants and children [30]. The literature
evidence supporting the preventive effects of hydrolysed infant formulas for asthma is inconsistent
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and insufficient. Some studies suggest that certain partially- or extensively-hydrolysed formulas may
reduce the risk of asthma compared to non-hydrolysed formulas for children with a family history of
atopic disease [30,42,43]. In contrast, it was reported by others that infants who received hydrolysed
cow’s milk formula did not have a lower risk of asthma compared with those who received human
breast milk or standard cow’s milk formula [31].
Although several studies examined the association between different infant formulas and
asthma [30,31,34,42,44], this study uniquely distinguished between breast milk and any type of
MOTBM. Our results revealed that in comparison with infants who received breast milk only, those
who received MOTBM during the first 6 months after birth had a 71% increased risk of persistent
asthma at the age of 3 (ARR: 1.71, 95% CI: 1.03–2.83, p = 0.038). This association was independent of
established maternal and environmental risk factors.
Previous findings regarding duration of breastfeeding and the risk of asthma are contradictory.
Although several studies showed that breastfeeding prevents asthma [45,46], there were also several
disagreeing studies [26,47]. This study found no significant association between duration of
breastfeeding up to 6 months and development of persistent asthma in the first 3 years of life (RR: 1.13,
95% CI: 0.70–1.83). This finding is consistent with previous studies carried out in Denmark and
Sweden, which have shown that breastfeeding does not lower the risk of childhood asthma (OR: 1.08,
95% CI: 0.93–1.25) and (OR: 0.99, 95% CI: 0.96–1.02) respectively [47,48].
Gender appears to be a factor in the development of asthma, i.e., boys in general are reported to
have more severe asthma than girls [49]. This was suggested to be the result of smaller airway diameters
relative to lung volume in boys compared to girls [50,51]. Consistent to what was observed in these
studies [49,52] more males (10.4%) than females (3.4%) in our study were diagnosed with persistent
asthma with strong association between sex differences and development of asthma (p-value < 0.001).
There is evidence suggests the existence of a complex relationship between eczema and asthma.
Research found that the majority of infants with early eczema develop asthma in childhood; an example
of the so-called “atopic march” [23]. Researchers suggested that understanding the relationship
between eczema and asthma might help in preventing asthma developing in these vulnerable children,
i.e., to prevent the atopic march. Demehri and his colleagues reported the existence of many theories
about the link between eczema and asthma. One theory suggests that the impairment of skin, which is
body’s protective external barrier, might stimulate the immune system to over-react to any potential
allergen present in the body, including the surface of the airways in the lungs [53]. In line with
several previous studies [23,54,55], we found that eczema in infancy was strongly associated with
the development of asthma in children at the age of 3. Multivariable analyses showed that existence
of eczema at baseline increased the risk of developing asthma by about two-fold (RR: 2.15, 95% CI:
1.15–4.04, p = 0.017) relative to children without eczema at the beginning of the study.
Maternal smoking during pregnancy has been consistently associated with early childhood
asthma [56,57]. Passive fetal exposure to tobacco smoke during pregnancy has been reported by
numerous studies to result in reduced lung function in the early months of infant’s life, with a
dose–response relationship between exposure and decreased airway calibre in early life [58,59]. In our
study, there was a strong association between smoking during pregnancy and the development of
childhood asthma, indicative of a dose response relationship. Children who were exposed to high
level of tobacco smoke of more than 10 cigarettes/day had higher risk for development of asthma
(ARR: 4.23, 95% CI: 1.91–9.37, p < 0.001 for test for trend). These results are consistent with what was
previously reported by Tariq et al. [57], where the authors found that smoking during pregnancy was
associated with the development of childhood asthma at two years of age (RR: 2.2, 95% CI: 1.5–3.4,
p < 0.001).
In our study, young maternal age at delivery was also associated with an increased risk of asthma
in three-year old children. This finding is consistent with previous studies conducted in United
Kingdom and Finland [7,12]. Additionally, the 31–35 age group was also associated with an increased
risk of asthma in children. Including age in its continuous form in the final model gave a RR = 0.95
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with 95% CI: 0.91–0.99 (p = 0.036). This agrees with previous studies relating young maternal age with
increased risk of asthma irrespective of the weak effect size.
As demonstrated by several studies [13,19], maternal asthma was also associated with an increased
risk of childhood asthma. Inconsistently, our univariate analysis did not show any such association
in three-year old children. It is worth mentioning that maternal asthma was not included in our
multivariable analysis as the variable regarding this issue was asked only to QLD state participants.
It has been hypothesized that caesarean section might increase the risk for developing asthma compared
to vaginal delivery, as a result of depriving the newborn of exposure to maternal microflora [60].
A number of studies found that caesarean section might have a positive association with development
of asthma [60,61]. In the present study, we did not observe similar associations. Researchers argue
that mothers with lower levels of education receive limited social support and may have decreased
access to health information. Overall, this increases the exposure to risk factors that affects mothers,
and consequently, their children’s health negatively [15,62]. Our built multivariable model did not
include maternal education as risk factor for development of asthma although it was a risk factor in
the univariate analysis.
There are several limitations of this study that are consistent with biases likely to arise from
cohort studies. Firstly, the recruitment was through three public maternity hospitals only in the
participating districts (Logan, Gold Coast and the Tweed Hospitals) limiting the generalizability in
other populations. As children included in the study were offspring of women who planned to
give birth in one of these hospitals, there is a potential for selection bias. Secondly, this study has a
relative low follow-up rate (49%) naturally stemming from the original EFHL study. The systematic
differences between the characteristics of children remaining in the study and those lost to follow-up
are likely to introduce bias. Thirdly, the use of self-report questionnaires to collect the information from
primary carers may lead to recall bias as evidenced in other cohort studies [27,63]. Lastly, the outcome,
medically-diagnosed asthma was addressed by a question asked at both waves 1 and 2. As the question
was based on information reported by the carer, there is possibility that it does not accurately predict
medically-diagnosed asthma in children. Moreover, asthma was medically diagnosed among children
less than 3 years of age; this study acknowledges the challenges of such diagnosis before the age of
5 [9]. Similarly, there is a possibility of misclassification of the exposure variable, MOTBM at less than
six months after birth. All these limitations may lead to imprecise risk estimation.
The strengths of this study lie in its large sample size, its prospective design, and the use of
carefully constructed questionnaires to maximize accuracy and completeness through asking specific
questions, which decreased recall bias of results. In addition, asthma was diagnosed by a physician
and not by parental self-report of symptoms.
In summary, the current study indicates that the introduction of MOTBM during the first
six months after birth is a risk factor for asthma in three-year old children. Although more studies
and further analyses are needed to confirm these findings and to better understand the underlying
mechanisms, public health interventions promoting the risk of early introduction of MOTBM and
encouraging mothers to refrain from using it during the first six months after birth may help in reducing
the morbidity and prevalence of childhood asthma. In support of previous research, the current data
did not show a correlation between breastfeeding and protection against asthma.
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